Vimta Labs (VIMTALABS)
STALWARTFairStock Score: 25/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹472.65 |
| Market Cap | ₹2,017.73 Cr |
| P/E Ratio | 26.6 |
| ROCE | 25.22% |
| ROE | 22.1% |
| Dividend Yield | 0.22% |
| Profit Growth | 6.91% |
| Debt/Equity | 0.02 |
| Sales Growth | 9.69% |
| Promoter Holding | 35.9% |
| 52-Week Range | ₹376.05 — ₹902.65 |
| Sector | Healthcare Services |
| Book Value | ₹76.61 |
Vimta Labs trades with a P/E ratio of 26.6, ROCE of 25.22%, ROE of 22.1%, profit growth of 6.91%, debt-to-equity of 0.02. The FairStock Score of 25/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer